A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies

NCT06049667 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Interventions

DRUG: NTQ2494 tablet

Sponsor

Nanjing Chia-tai Tianqing Pharmaceutical